Figure 2
From: Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
Pre- and post- 6-month average cost for treatment with duloxetine versus venlafaxine XR (Wilcoxon signed-rank test for pre and post comparison). Total cost, medical cost and pharmacy cost are significantly changed from prior 6-month to post 6-month (P < 0.05). XR = extended release; Total = total cost; Medical = total medical cost; Rx = total pharmacy costs. All comparisons of cost between cohorts (Wilcoxon rank-sum test) are statistically significant (P < 0.005).